Department of Biotechnology

Global Bio-India 2023 attracts global interest for India's $300 billion biotech potential from companies, academia, and start-ups

Retrieved on: 
Monday, December 4, 2023

Global Bio-India 2023 would be the largest congregation of biotech startups.

Key Points: 
  • Global Bio-India 2023 would be the largest congregation of biotech startups.
  • The central theme of Global Bio-India 2023 is Biotech Innovation and Bio-manufacturing.
  • Global Bio-India 2023 is not just an event; it's an opportunity to shape the future of biotechnology on a global scale  ( Source ).
  • The participation of US biotech leaders in India underscores the strategic importance of the collaboration between two global biotechnology giants.

Game-changing Indian MRI Scanner Launched: Targets 6 billion People without Access to Cutting-edge Imaging Technologies

Retrieved on: 
Monday, August 7, 2023

NEW DELHI, Aug. 7, 2023 /PRNewswire/ -- In a groundbreaking development, India-based company Voxelgrids has launched an advanced and affordable MRI scanner with the potential to revolutionize healthcare accessibility not only in India but also worldwide. With funding from BIRAC (Biotechnology Industry Research Assistance Council), an institution set up by the Department of Biotechnology (DBT), Government of India, to nurture and promote biotechnology innovations and industry in India, Voxelgrids has successfully developed a cutting-edge MRI (Magnetic Resonance Imaging) scanner that is significantly more affordable than traditional counterparts, breaking down barriers to access for billions of people previously unable to afford the procedure.

Key Points: 
  • Game-changing Indian MRI Scanner Launched: Targets 6 billion People without Access to Cutting-edge Imaging Technologies
    The global MRI equipment industry reached USD 7.08 billion in 2022, and is projected to grow to USD 11.50 billion by 2030, exhibiting a CAGR of 6.3% during the forecast period.
  • Although the global MRI industry has grown significantly, a staggering 70 percent of the world's population still lacks access to MRI machines.
  • Addressing this challenge, an Indian company has introduced an affordable MRI scanner, offering cost benefits of up to USD 800,000 compared to the conventional models.
  • The low-cost MRI scanner is set to transform the healthcare landscape, empowering healthcare providers to serve diverse communities and drive positive health outcomes globally.

Bugworks Research Inc welcomes Dr. Renu Swarup to its Global Advisory Board

Retrieved on: 
Wednesday, February 22, 2023

BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/ -- Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board. Dr. Swarup is the former Secretary, Department of Biotechnology, Government of India and brings in more than three decades of experience in the biotech sector. 

Key Points: 
  • Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist joins the Advisory Board to provide strategic guidance to the project portfolio of Bugworks Research
    BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/ -- Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board.
  • Speaking on her appointment, Dr. Anand Anandkumar - CEO, Bugworks Research states, "Bugworks is pleased to welcome Dr. Renu Swarup as a member of its Global Advisory Board.
  • We look forward to working closely with Dr. Swarup to help us reach our goal of enabling equitable global access to Bugworks' innovative products."
  • On joining Bugworks Research, Dr. Renu Swarup said, "I am pleased to be associated with Bugworks in my capacity as an Honorary Advisor and member of their Global Advisory Board.

Bugworks Research Inc welcomes Dr. Renu Swarup to its Global Advisory Board

Retrieved on: 
Wednesday, February 22, 2023

BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/ -- Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board. Dr. Swarup is the former Secretary, Department of Biotechnology, Government of India and brings in more than three decades of experience in the biotech sector. 

Key Points: 
  • Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist joins the Advisory Board to provide strategic guidance to the project portfolio of Bugworks Research
    BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/ -- Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board.
  • Speaking on her appointment, Dr. Anand Anandkumar - CEO, Bugworks Research states, "Bugworks is pleased to welcome Dr. Renu Swarup as a member of its Global Advisory Board.
  • We look forward to working closely with Dr. Swarup to help us reach our goal of enabling equitable global access to Bugworks' innovative products."
  • On joining Bugworks Research, Dr. Renu Swarup said, "I am pleased to be associated with Bugworks in my capacity as an Honorary Advisor and member of their Global Advisory Board.

World Cattle Healthcare Market Outlook and Opportunity Analysis Report 2022-2028 Featuring Idexx Laboratories, Boehringer Ingelheim, Virbac, Elanco, IDVet, Zoetis, Bayer, Merck & Co and Ceva - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 29, 2022

The "Cattle Healthcare Market By Product, By Diagnostic Type, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cattle Healthcare Market By Product, By Diagnostic Type, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • Cattle healthcare is one of the major aspects of animal husbandry as it has direct co-relation with productivity and outcome from animal husbandry.
  • The global cattle healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cattle healthcare market.

AI In Cancer Diagnostics Market Analysis Report 2022 Featuring Earlysign, Cancer Center.Ai, Microsoft, Flatiron, Path Ai, Therapixel, Tempus, Paige Ai, Kheiron Medical Technologies, Skinvision - ResearchAndMarkets.com

Retrieved on: 
Friday, December 16, 2022

Rising prevalence of cancer and growing demand for the early detection of the condition are some of the key factors driving the market.

Key Points: 
  • Rising prevalence of cancer and growing demand for the early detection of the condition are some of the key factors driving the market.
  • Growing prevalence of cancer globally is expected to increase the demand for Artificial Intelligence (AI) in cancer diagnostics, thereby contributing to the market growth.
  • According to data published by the American Cancer Society, 1.9 million new cases of cancer were diagnosed and more than 600,000 deaths occurred in 2021 in the U.S.
  • Increased demand to accurately and effectively diagnose cancer is expected to further increase the adoption of the technology for diagnosis.

AI In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component, By Cancer Type, By End-user, By Region And Segment Forecasts, 2022 - 2030

Retrieved on: 
Monday, November 7, 2022

Key Points: 
  • NEW YORK, Nov. 7, 2022 /PRNewswire/ -- AI In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By End-user, By Region, And Segment Forecasts, 2022 - 2030
    The global AI in cancer diagnostics market size is expected to reach USD 996.1 million by 2030.
  • The market is expected to expand at a CAGR of 28.0% from 2022 to 2030.
  • Rising prevalence of cancer and growing demand for the early detection of the condition are some of the key factors driving the market.
  • Growing prevalence of cancer globally is expected to increase the demand for Artificial Intelligence (AI) in cancer diagnostics, thereby contributing to the market growth.

Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year”

Retrieved on: 
Thursday, November 3, 2022

Longhorn Vaccines & Diagnostics , a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced it has been named Diagnostics Company of the Year in the second annual BioTech Breakthrough Awards program.

Key Points: 
  • Longhorn Vaccines & Diagnostics , a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced it has been named Diagnostics Company of the Year in the second annual BioTech Breakthrough Awards program.
  • Our goal is to improve the delivery of molecular diagnostics to serve critical unmet needs in both the developed and developing world, said Longhorn Vaccines and Diagnostics President Jeff Fischer.
  • We offer a heartfelt congratulations on being our choice for Diagnostics Company of the Year!
  • Longhorn Vaccines and Diagnostics LLC is a One Health and One World company based in Maryland that is developing vaccines and diagnostic tools for worldwide public health concerns and to prevent future pandemics.

Oligonucleotide Synthesis Market Report 2022: Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 6, 2022

The "Oligonucleotide Synthesis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Oligonucleotide Synthesis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and clinical applications.
  • They are very useful for carrying out molecular diagnosis in several diseases, like the detection of infectious diseases, such as hepatitis.
  • For instance, In January 2020, the Department of Biotechnology (DBT) initiated the "Genome India Project" (GIP).

InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update

Retrieved on: 
Friday, September 23, 2022

The Companys full financial statements and related MD&A for the fiscal year ended June 30, 2022, will be available at www.inmedpharma.com and at www.sedar.com .

Key Points: 
  • The Companys full financial statements and related MD&A for the fiscal year ended June 30, 2022, will be available at www.inmedpharma.com and at www.sedar.com .
  • InMed is evaluating the safety of INM-755 (cannabinol) cream and its preliminary efficacy in treating symptoms and wound healing over a 28-day treatment period.
  • In the second half of fiscal 2022 and during the subsequent months, InMed and its BayMedica subsidiary implemented significant cost saving measures, including some personnel changes.
  • Also, as part of these expense reduction initiatives, no employee received an annual performance bonus for fiscal year 2022.